Meta Legal Risks, mRNA Breakthroughs, and Lithium Cycles
An executive analysis of Meta's legal exposure and AI capex, Moderna's Phase 3 oncology success, and Albemarle's lithium market position. This brief highlights the shift from speculative AI growth to selective profitability and the cyclical opportunities in energy storage materials.